Terms: = Leukemia AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Treatment
70 results:
1. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract] [Full Text] [Related]
2. Germline
Bochicchio MT; Micucci G; Asioli S; Ghetti M; Simonetti G; Lucchesi A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003211
[TBL] [Abstract] [Full Text] [Related]
3. [Chronic neutrophilic leukemia/chronic eosinophilic leukemia].
Kawashima I; Kirito K
Rinsho Ketsueki; 2023; 64(10):1326-1334. PubMed ID: 37914248
[TBL] [Abstract] [Full Text] [Related]
4. [Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia].
Yokoi M; Kondo T; Shimizu R; Uchida K; Hayashi S; Nishimura H; Kondo E; Wada H
Rinsho Ketsueki; 2023; 64(8):735-740. PubMed ID: 37673624
[TBL] [Abstract] [Full Text] [Related]
5. [Impact of
Li RQ; Wen XL; Zhang XL; Dong CX; Wang MF; Liu XX; Huang YJ; Tan YH; Chang JM; Zhang RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):628-632. PubMed ID: 37356918
[TBL] [Abstract] [Full Text] [Related]
6. [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on csf3r mutations and measurable residual disease].
Su L; Tan YH; Lin H; Han W; Yang YP; Liu XL; Sun JN; Liu QJ; Gao SJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1021-1027. PubMed ID: 36709108
[No Abstract] [Full Text] [Related]
7. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
Harada S; Okada K; Yokoyama S; Hidaka D; Hayase E; Onozawa M; Goto H; Hashimoto D; Kahata K; Endo T; Teshima T
Rinsho Ketsueki; 2021; 62(11):1609-1614. PubMed ID: 34866084
[TBL] [Abstract] [Full Text] [Related]
8. Current Management of Chronic Neutrophilic leukemia.
Szuber N; Tefferi A
Curr Treat Options Oncol; 2021 Jun; 22(7):59. PubMed ID: 34097138
[TBL] [Abstract] [Full Text] [Related]
9. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
Dannenmann B; Klimiankou M; Oswald B; Solovyeva A; Mardan J; Nasri M; Ritter M; Zahabi A; Arreba-Tutusaus P; Mir P; Stein F; Kandabarau S; Lachmann N; Moritz T; Morishima T; Konantz M; Lengerke C; Ripperger T; Steinemann D; Erlacher M; Niemeyer CM; Zeidler C; Welte K; Skokowa J
Cell Stem Cell; 2021 May; 28(5):906-922.e6. PubMed ID: 33894142
[TBL] [Abstract] [Full Text] [Related]
10. Primary varicella-zoster virus infection of the immunocompromised associated with acute pancreatitis and hemophagocytic lymphohistiocytosis: A case report.
Bérar A; Ardois S; Walter-Moraux P; Jegonday MA; Henriot B
Medicine (Baltimore); 2021 Apr; 100(16):e25351. PubMed ID: 33879665
[TBL] [Abstract] [Full Text] [Related]
11. csf3r T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
Qian Y; Chen Y; Li X
Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
[TBL] [Abstract] [Full Text] [Related]
12. Effect of the unfolded protein response and oxidative stress on mutagenesis in csf3r: a model for evolution of severe congenital neutropenia to myelodysplastic syndrome/acute myeloid leukemia.
Sapra A; Jaksik R; Mehta H; Biesiadny S; Kimmel M; Corey SJ
Mutagenesis; 2020 Dec; 35(5):381-389. PubMed ID: 33511998
[TBL] [Abstract] [Full Text] [Related]
13. Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib.
Bornemann L; Schuster M; Schmitz S; Sobczak C; Bessen C; Merz SF; Jöckel KH; Haverkamp T; Gunzer M; Göthert JR
BMC Cancer; 2020 Jul; 20(1):650. PubMed ID: 32660441
[TBL] [Abstract] [Full Text] [Related]
14. [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
Fan LF; Xu J; Chen XH; Tian TT; Xie J; Hu JJ; Guo ZP; Tan YH; Xu ZF; Ren FG; Zhang YF; Luo M; Ren WX; Wang HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):781-788. PubMed ID: 32552936
[TBL] [Abstract] [Full Text] [Related]
15. Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in csf3r/CEBPA mutant acute myeloid leukemia.
Braun TP; Coblentz C; Curtiss BM; Coleman DJ; Schonrock Z; Carratt SA; Callahan RL; Maniaci B; Druker BJ; Maxson JE
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13670-13679. PubMed ID: 32471953
[TBL] [Abstract] [Full Text] [Related]
16. SWATH-Proteomics of Ibrutinib's Action in Myeloid leukemia Initiating Mutated G-CSFR Signaling.
Dwivedi P; Chutipongtanate S; Muench DE; Azam M; Grimes HL; Greis KD
Proteomics Clin Appl; 2020 Sep; 14(5):e1900144. PubMed ID: 32319217
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of Clinical Features and Prognosis of Patients with Chronic Neutrophil leukemia].
Guo YJ; Wang Y; Wang LH; Zuo YB; Niu ZY; Lin FR; Zhang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):82-87. PubMed ID: 32027257
[TBL] [Abstract] [Full Text] [Related]
18. Novel treatment strategies for myeloproliferative neoplasms.
Bose P; Masarova L; Verstovsek S
Rinsho Ketsueki; 2019; 60(9):1176-1185. PubMed ID: 31597841
[TBL] [Abstract] [Full Text] [Related]
19. Altered expression of csf3r splice variants impacts signal response and is associated with SRSF2 mutations.
Lance A; Druhan LJ; Vestal CG; Steuerwald NM; Hamilton A; Smith M; Price A; Tjaden E; Fox AN; Avalos BR
Leukemia; 2020 Feb; 34(2):369-379. PubMed ID: 31462738
[TBL] [Abstract] [Full Text] [Related]
20. Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.
Yılmaz Karapınar D; Patıroğlu T; Metin A; Çalışkan Ü; Celkan T; Yılmaz B; Karakaş Z; Karapınar TH; Akıncı B; Özkınay F; Onay H; Yeşilipek MA; Akar HH; Tüysüz G; Tokgöz H; Özdemir GN; Aslan Kıykım A; Karaman S; Kılınç Y; Oymak Y; Küpesiz A; Olcay L; Keskin Yıldırım Z; Aydoğan G; Gökçe M; İleri T; Aral YZ; Bay A; Atabay B; Kaya Z; Söker M; Özdemir Karadaş N; Özbek U; Özsait Selçuk B; Özdemir HH; Uygun V; Tezcan Karasu G; Yılmaz Ş
Pediatr Blood Cancer; 2019 Oct; 66(10):e27923. PubMed ID: 31321910
[TBL] [Abstract] [Full Text] [Related]
[Next]
